Home » Topics » BioWorld Science

BioWorld Science
RSS

Resolvin D2 for treating Duchenne muscular dystrophy

Dec. 1, 2021

Arbutus Biopharma synthesizes new HBV and HDV antivirals

Dec. 1, 2021

Orion identifies new CYP11A1 inhibitors

Dec. 1, 2021

Quretech Bio presents compounds for Gram-positive bacterial infections

Dec. 1, 2021

Roche patents new GABRA5 PAMs

Dec. 1, 2021

CSPC Zhongqi Pharmaceutical Technology divulges tyrosine kinase receptor inhibitors

Dec. 1, 2021

CLIP1-LTK gene fusion promotes NSCLC development

Dec. 1, 2021

NP-10679 results in potent neuroprotection in preclinical models

Dec. 1, 2021

Hepatic gene transfer with AAV-GAA leads to enhanced enzyme bioavailability in vivo

Dec. 1, 2021

PQBP1 expression in microglia is important for tau-induced inflammation in the brain

Dec. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.